Zhaoying Yang

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

PNMA1 is a novel immune modulator and therapeutic target in hepatocellular carcinoma linked to bile acid metabolism.

PNMA1 is a novel immune modulator and therapeutic target in hepatocellular carcinoma linked to bile acid metabolism.

Journal: Scientific reports
Published: August 27, 2024

Key Magnetized Exosomes for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Cell Types in Mice Model.

Key Magnetized Exosomes for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Cell Types in Mice Model.

Journal: International journal of nanomedicine
Published: July 15, 2024

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel.

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel.

Journal: Scientific reports
Published: June 03, 2024

Targeting oncogenic MAGEA6 sensitizes triple negative breast cancer to doxorubicin through its autophagy and ferroptosis by stabling AMPKα1.

Targeting oncogenic MAGEA6 sensitizes triple negative breast cancer to doxorubicin through its autophagy and ferroptosis by stabling AMPKα1.

Journal: Cell death discovery
Published: May 07, 2024

The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.

The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.

Journal: PeerJ
Published: October 28, 2022

Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.

Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.

Journal: PloS one
Published: November 28, 2021

TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway.

TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway.

Journal: BMC cancer
Published: June 02, 2021

Follicular dendritic cell sarcoma in the right chest wall: A case report.

Follicular dendritic cell sarcoma in the right chest wall: A case report.

Journal: Medicine
Published: September 03, 2020

Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.

Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.

Journal: International journal of genomics
Published: June 23, 2020

Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer.

Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer.

Journal: OncoTargets and therapy
Published: May 30, 2020

Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Journal: Medicine
Published: February 01, 2020

Rab22a is a novel prognostic marker for cell progression in breast cancer.

Rab22a is a novel prognostic marker for cell progression in breast cancer.

Journal: International journal of molecular medicine
Published: July 10, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026